329 related articles for article (PubMed ID: 2532368)
21. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Heinrich G
N Engl J Med; 1989 Oct; 321(17):1197. PubMed ID: 2571933
[No Abstract] [Full Text] [Related]
22. Diffuse senile plaques: amorphous or fibrous?
Bugiani O; Tagliavini F; Giaccone G; Verga L; el-Hachimi K; Foncin JF; Frangione B
Am J Pathol; 1995 Mar; 146(3):777-9. PubMed ID: 7887458
[No Abstract] [Full Text] [Related]
23. Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody.
Ikeda S; Wong CW; Allsop D; Landon M; Kidd M; Glenner GG
Lab Invest; 1987 Oct; 57(4):446-9. PubMed ID: 3312810
[TBL] [Abstract][Full Text] [Related]
24. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
[TBL] [Abstract][Full Text] [Related]
25. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
Kang J; Lemaire HG; Unterbeck A; Salbaum JM; Masters CL; Grzeschik KH; Multhaup G; Beyreuther K; Müller-Hill B
Nature; 1987 Feb 19-25; 325(6106):733-6. PubMed ID: 2881207
[TBL] [Abstract][Full Text] [Related]
26. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
Coria F; Castaño EM; Frangione B
Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
[TBL] [Abstract][Full Text] [Related]
27. The neuropathology of Alzheimer's disease.
Wisniewski HM; Wegiel J
Neuroimaging Clin N Am; 1995 Feb; 5(1):45-57. PubMed ID: 7743084
[TBL] [Abstract][Full Text] [Related]
28. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
[TBL] [Abstract][Full Text] [Related]
29. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
Ikeda S; Yanagisawa N; Allsop D; Glenner GG
Lab Invest; 1989 Jul; 61(1):133-7. PubMed ID: 2473275
[TBL] [Abstract][Full Text] [Related]
30. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
[TBL] [Abstract][Full Text] [Related]
31. Immunogold electron microscopic study of cerebrovascular and senile plaque amyloid using anti-beta protein antibody.
Okamoto K; Yamaguchi H; Hirai S; Shoji M; Inoue K; Takatama M
Prog Clin Biol Res; 1989; 317():953-63. PubMed ID: 2690130
[TBL] [Abstract][Full Text] [Related]
32. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.
Iwatsubo T; Saido TC; Mann DM; Lee VM; Trojanowski JQ
Am J Pathol; 1996 Dec; 149(6):1823-30. PubMed ID: 8952519
[TBL] [Abstract][Full Text] [Related]
33. [An Alzheimer's disease case showing recurrent subcortical hemorrhage: an autopsy findings with immunohistochemical studies of cerebral amyloid deposits].
Maruyama K; Ikeda S; Odajima N; Yanagisawa N
Rinsho Shinkeigaku; 1989 Jul; 29(7):936-9. PubMed ID: 2805520
[TBL] [Abstract][Full Text] [Related]
34. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer patients: preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system.
Bugiani O; Giaccone G; Frangione B; Ghetti B; Tagliavini F
Neurosci Lett; 1989 Sep; 103(3):263-8. PubMed ID: 2478933
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.
Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
Lab Invest; 1989 Nov; 61(5):576-83. PubMed ID: 2478759
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
38. Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.
Koudinova NV; Berezov TT; Koudinov AR
Biochemistry (Mosc); 1999 Jul; 64(7):752-7. PubMed ID: 10424897
[TBL] [Abstract][Full Text] [Related]
39. Down syndrome and Alzheimer disease.
Hyman BT
Prog Clin Biol Res; 1992; 379():123-42. PubMed ID: 1409740
[TBL] [Abstract][Full Text] [Related]
40. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
Thal DR; Ghebremedhin E; Haass C; Schultz C
Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
